3D Signatures, MDxHealth Partner to Develop Less-invasive Telo-PC Prognostic Test
News
A new, minimally invasive prognostic test to improve treatment of prostate cancer, called Telo-PC, will be developed following the establishment of a collaborative agreement between 3D Signatures and Belgium-based MDxHealth. ... Read more